Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Advanced search

Search projects and results

Results 1 - 10 of 145
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Improved health care provision through the development of an automated process for high-level recombinant protein production in mammalian cells
ID: QLK3-CT-2002-71343
Start date: 2003-04-01, End date: 2005-03-31
Programme: FP5-LIFE QUALITY
Record Number: 70073
Last updated on: 2013-09-20
Cord blood as an allogeneic source of stem cell for clinical use
ID: QLK3-CT-1999-00380
Start date: 2000-01-01, End date: 2002-12-31
Cord blood cells, collected at birth, have new interesting properties which can be used for treatment of leukemias and other malignant diseases and also for the treatment of genetic or acquired hematological disorders. Cord blood banks have been established worldwide, and tha...
Programme: FP5-LIFE QUALITY
Record Number: 52363
Last updated on: 2006-06-13
Optimising nutritional quality of crops
ID: QLK3-CT-2000-00103
Start date: 2001-02-01, End date: 2004-09-30
The major limiting essential amino acids in crops are lysine and motioning. The amount of these amino acids determines the nutritional quality of a crop as food or feed raw material. This project proposal aims at improving the composition of free and protein bound amino acids ...
Programme: FP5-LIFE QUALITY
Record Number: 54671
Last updated on: 2006-06-13
DNA replication and biotechnological applications
ID: QLK3-CT-2002-02071
Start date: 2003-01-01, End date: 2005-12-31
DNA replication is a key process involved in cell division of all living creatures. Based on the structural and functional homology between archaic andeukaryotes, this project proposes to co-ordinate efforts of one SME and seven laboratories from five European countries on the...
Programme: FP5-LIFE QUALITY
Record Number: 67233
Last updated on: 2006-06-13
Allergen-derived DNA vaccines: mechanisms involved in mouse and human models
ID: QLK3-CT-2002-02026
Start date: 2002-12-01, End date: 2006-02-28
Aim of the project is to exploit the experience (of a previous EC-funded study) to investigate mechanisms of immunological modifications induced by allergen- (of Mite and Parietaria pollens) encoding DNA vaccines. Their effects will be directly investigated on APCs and on the ...
Programme: FP5-LIFE QUALITY
Record Number: 67190
Last updated on: 2006-06-13
Profiling metalloprotease inhibition for tumour therapy
[PROJECT] PROFILING MMP INHIBITI - Profiling metalloprotease inhibition for tumour therapy
ID: QLK3-CT-2002-02136
Start date: 2003-01-01, End date: 2006-03-31
Inhibitors of metalloproteinases have shown a high therapeutic potency in preliminary clinical trials. However, unacceptable side-effects are associated, which are relative to recently discovered ADAMS and "non classical" effects of MMPs. This project aims at defining the best...
Programme: FP5-LIFE QUALITY
Record Number: 72690
Last updated on: 2006-06-13
Demonstrating the applicability of novel indices of immunological tolerance to clinical practice using immunosuppression-free transplant recipients
ID: QLK3-CT-2002-02127
Start date: 2003-01-01, End date: 2006-08-31
Patients who have received transplants generally require life-long immunosuppressive drugs, which are all associated with potentially life- threatening adverse effects. Occasionally, "tolerant" patients have been able to stop these drugs without losing their grafts, but we can...
Programme: FP5-LIFE QUALITY
Record Number: 72689
Last updated on: 2006-06-13
Biochemical and functional characterization of antigen presenting cell derived-exosomes: the design of a cell free cancer vaccine
ID: QLK3-CT-2001-00093
Start date: 2002-01-01, End date: 2005-12-31
This proposal is a combined R&D and demonstration project aimed at developing a novel therapeutic substance effective as cancer vaccine. The consortium has a unique expertise in a novel cell free vaccine i.e. the exosomes, 60-90 nm antigen presenting membrane vesicles of endos...
Programme: FP5-LIFE QUALITY
Record Number: 64513
Last updated on: 2006-06-13
Detection of early markers In Mammography
ID: QLK3-CT-2001-01318
Start date: 2001-12-01, End date: 2006-09-30
Some lethal diseases, such as Breast Cancer, can be effectively treated if diagnosed early in their development. Thus periodic widespread screening of women above a certain age is desirable. Such practice can greatly benefit from a reduction of the radiation doses delivered by...
Programme: FP5-LIFE QUALITY
Record Number: 64547
Last updated on: 2006-06-13
Clearance of apoptotic cells: discovery of autoantigens and therapy for autoimmune diseases
ID: QLK3-CT-2002-02017
Start date: 2002-11-01, End date: 2006-04-30
The clearance of dying cells is the last phase of apoptosis in vivo. Corpse removal prevents inflammation and autoimmunity. We plan to develop therapeutic strategies aimed to restore in vivo clearance, in order to prevent tissue damage and chronic inflammation. To this aim we ...
Programme: FP5-LIFE QUALITY
Record Number: 67241
Last updated on: 2006-06-13
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-12-11
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top